SCHEMBL15984792

SCHEMBL15984792

Cc1ccc(-c2ccc(-c3nccn3C)cc2)c(C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 3/20 0.41
CDK8 P49336 3/20 0.41
HDAC4 P56524 2/20 0.41
EDNRA P25101 1/20 0.41
KDM5B Q9UGL1 1/20 0.38
BRD4 O60885 1/20 0.38
NMT1 P30419 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
KDM4E B2RXH2 2/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CREBBP Q92793 1/20 0.34
NPC1 O15118 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
PDE10A Q9Y233 1/20 0.33
LRRK2 Q5S007 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15980684 0.82 KDM5B (0.43) CCNCCDK8HDAC4EDNRAKDM5B
SCHEMBL10194263 0.75 KDM4E (0.51) CCNCCDK8HDAC4EDNRAKDM5B
SCHEMBL17795529 0.73 CYP1A2 (0.40) KDM4EL3MBTL1NPC1RAB9AGRIA2
SCHEMBL9451409 0.72 HDAC4 (0.47) CCNCCDK8HDAC4EDNRAKDM5B
SCHEMBL2326291 0.72 IDO1 (0.47) CCNCCDK8HDAC4EDNRAKDM5B
SCHEMBL10558737 0.72 NR1H2 (0.45) HDAC4KDM5BBRD4KDM4EHSD17B10
SCHEMBL3462133 0.72 HDAC4 (0.46) CCNCCDK8HDAC4EDNRAKDM5B
SCHEMBL77337 0.72 HDAC4 (0.47) CCNCCDK8HDAC4EDNRAKDM5B
SCHEMBL16628325 0.72 HDAC4 (0.43) CCNCCDK8HDAC4EDNRAKDM5B
SCHEMBL9281044 0.72 HDAC4 (0.54) CCNCCDK8HDAC4EDNRABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9216173-B2 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors MERCK SHARP & DOHME CORP. (US) 2015-12-22 US disclosed
US-20140243336-A1 2-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors MERCK SHARP & DOHME LLC 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243336-A1 2-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors SYK, BTK, LCK CCNC 2545/4885CDK8 863/4885HDAC4 1375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.